Dr. Kevin Y. Jong, MD

Dr. Jong practices at Houston Eye Surgery Center in Houston, Texas.

Dr. Jong's NPI, 1124013214, was assigned on September 14, 2005. Dr. Jong graduated from Baylor College Of Medicine in 1992. Dr. Jong's Texas license number on file is K1489.

Dr. Jong's primary practice is Houston Eye Surgery Center, at 2855 Gramercy St, Houston, TX 77025 in Harris County. The practice phone is (832) 553-7171.

Dr. Jong's primary practice is Houston Eye Surgery Center in Houston, Texas. Dmand AI also links Dr. Jong to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jong practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Jong's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Jong is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Jong's licenses on file in 3 states: Texas, Louisiana and Oklahoma.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Jong treats.

CMS data shows 1,340 Medicare services from Dr. Jong across 13 procedure codes in 2024, for 550 Medicare patients. Medicare paid $124,598 for them.

CMS counts 550 Medicare patients who saw Dr. Jong in 2024. The largest group is 65 to 74, with 248 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jong's median patient age at 74, with 59% women.

In 2024, Dr. Jong wrote 8,393 Medicare Part D claims for 1,641 patients. 35% of them were for generic drugs. CMS names the drug for 8,268 of them, across 31 drugs with 11 or more claims each, at $1,065,581 in total drug cost. In 2023, CMS named 8,067 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Jong for performance year 2024, reported as part of a group. Dr. Jong accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 272 procedures of cataract surgery by Dr. Jong, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Jong, published from 2017 to 2025. The most frequent topics are Cataract, Double-Blind Method and Ophthalmic Solutions. Dr. Jong's most frequent co-authors are Joseph N. Martel, Louis Max Alpern, MD and Jason Bacharach, MD.

Dmand AI links Dr. Jong to 3 clinical trials. Conditions studied include Cataract and Lens Diseases. Bausch & Lomb Incorporated sponsors the most, 2. Open Payments lists research payments to Dr. Jong that name 2 trials.

CMS Open Payments shows 519 general payments to Dr. Jong from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Valeant Pharmaceuticals International paid the most, $5,268. It also lists 9 research payments totaling $316,560 from 2018 to 2020, naming 2 clinical trials.

Dmand AI lists 2 awards for Dr. Jong, most recently CMS Stage 1 EHR in 2013.

Dr. Jong graduated from Baylor College Of Medicine in 1992. Dr. Jong is a member of AAO.

Dr. Jong is in network with 22 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.